Newsroom
Sorted by: Latest
-
Aftermarket Car Telematics Market Report, 2024 and 2025-2029: Remote Diagnostics and Data Integration Transform Aftermarket Car Services - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Aftermarket Car Telematics - 6th Edition" report has been added to ResearchAndMarkets.com's offering. Aftermarket Car Telematics is the sixth consecutive report analysing the latest developments on the market for applications such as stolen vehicle tracking (SVT), vehicle diagnostics, usage-based insurance, Wi-Fi hotspot, roadside assistance and convenience applications targeting consumers and businesses. This strategic research report provides you with 180 pages o...
-
India Ethanol Market Business Report 2025: PESTEL Analysis, Producers and Product Range, Export and Import, Major Wholesalers and Trading Companies, Consumers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Ethanol Market in India: Business Report 2025" report has been added to ResearchAndMarkets.com's offering. The report presents analysis of the ethanol market in India. Scope Brief country profile includes general information and main economic indicators and specifies business environment in India Ethanol market is analyzed by different parameters including domestic production and consumption. Future market development is also estimated Trade analysis covers data on...
-
Lawdragon Spotlights DOBS Partners for Leadership in High-Stakes Trial Litigation
DALLAS--(BUSINESS WIRE)--Dean Omar Branham Shirley name partners Jessica Dean and Trey Branham have been named to Lawdragon’s flagship 2026 500 Leading Lawyers in America guide, which recognizes attorneys nationwide for excellence and influence across the legal profession. The publication’s editors say, “this 500 is robust with lawyers who inspire us and will shape the law for decades to come.” “This honor belongs to the entire trial team,” Ms. Dean said. “The results we achieved in 2025 were o...
-
Law Offices of Frank R. Cruz Encourages Varonis Systems, Inc. (VRNS) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Varonis Systems, Inc. (VRNS) Shareholders To Inquire About Securities Fraud Class Action...
-
Dan Wheeler Announces Campaign for Congress in California's 11th District
SAN FRANCISCO--(BUSINESS WIRE)--Daniel Wheeler today announced his candidacy for the United States House of Representatives in California's 11th District, pledging to restore San Francisco's position as America's beacon of innovation, progress and common-sense leadership. San Francisco is overdue for representation by someone unbeholden to special interests or responsible for the misuse of public funds. Wheeler is laser focused on San Franciscans’ priorities: Economic Growth and Affordability:...
-
emeis : Programme de rachat de titres
PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Déclaration des transactions sur actions propres Période du 5 au 9 janvier 2026 Emetteur : EMEIS (LEI : 969500LHIH3NT7PK1V89) (Paris:EMEIS) Catégories de titres : actions ordinaires (ISIN : FR001400NLM4) Descriptif du programme mis en ligne sur le site Internet de l’Autorité des Marchés Financiers le 12 janvier 2026 Rapport hebdomadaire sur les rachats d'actions du 5 au 9 janvier 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI...
-
insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is expected to close in late January 2026, will complete insitro's full stack, modality-agnostic capability spanning small molecules, oligonucleotides, antibodies, and other complex biologics with precision – enabling biology to guide both mod...
-
Medincell: Publication of the 2026 Financial Calendar
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Event Date Annual results 2025-2026 (April 2025-March 2026) Tuesday, June 16, 2026 General Meeting Thursday, September 10, 2026 Half-Year results 2026-2027 (April-September 2026) Tuesday, December 8, 2026 About Medincell Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable treatments across multiple therapeutic areas. Our innovative treatments are design...
-
Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs
SAN FRANCISCO--(BUSINESS WIRE)--Owkin, the AI company on a mission to solve the complexity of biology, today announced the launch of its agentic infrastructure for biology, making its best-in-class AI agents available to the healthcare ecosystem. The announcement comes at the JPM Healthcare Conference 2026 and follows Owkin’s recent strategic partnerships and its just-announced integration with Claude for Healthcare and Life Sciences by Anthropic. Owkin, a 10-year-old AI company with $300 milli...
-
Liberty All-Star® Equity Fund Declares Distribution
BOSTON--(BUSINESS WIRE)--The Board of Trustees of Liberty All-Star Equity Fund (NYSE: USA) has declared a distribution of $0.18 per share payable on March 9, 2026 to shareholders of record on January 22, 2026. This distribution is in accordance with the Fund’s current distribution policy of paying distributions on its shares totaling approximately 10 percent of its net asset value per year, payable in four quarterly installments of 2.5 percent. A portion of the distribution may be treated as pa...